The invention relates to a pharmaceutical composition for enhancing bioavailability or bioefficacy of anti-HIV drug, comprising: a) a therapeutically effective amount of anti-HIV drug, b) an effective amount of quercetin, and c) a pharmaceutically acceptable excipient.